A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

NCT00000804 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)